>i really like this stock
Mark, so you should. The chart since last Oct looks terrific. Thanks, I'll buy some.
>Forest Laboratories Inc.'s experimental drug memantine appears to slow the progression of Alzheimer's disease symptoms in patients in the moderate-to-severe stage, a new study said.
Btw
Do you still own Amcc? Qcom gets most of the press down here in San Diego but I prefer Amcc because its flawless.
>San Diego, July 13 (Bloomberg) -- Shares of Applied Micro Circuits Corp., a maker of chips for communications equipment, rose as much as 21 percent after the company said fiscal first- quarter revenue more than doubled.
The shares surged 24 1/8 to 149 9/16 in midmorning trading after rising to 151 5/16. They have more than doubled this year as the company benefits from mounting demand for Internet services.
Applied Micro's fiscal first-quarter sales rose to $74.2 million, exceeding analysts' estimates of $67 million to $68 million. Applied Micro's book-to-bill ratio was 1.35 for the quarter, meaning the company received $1.35 of orders for every $1 of revenue. The average prices of its chips and profit margins are increasing, the company said.
``The outlook for the second half for the year is very bullish,'' said Salomon Smith Barney analyst Clark Westmont, who rates Applied Micro stock a ``buy.''
Net income in the quarter ended June 30 dropped by half to $3.4 million, or 3 cents a share, from $6.79 million, or 6 cents.
Excluding acquisition and other costs, the San Diego-based company had profit of $27.9 million, or 21 cents a share. On that basis, Applied Micro was expected to have profit of 17 cents a share, based on the average estimate of analysts polled by First Call/Thomson Financial.
Revenue totaled $31.6 million a year ago.
Applied Micro announced earnings yesterday after the close of regular U.S. trading. |
